Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF JUNE 06, 2014 FBO #4577
SOURCES SOUGHT

66 -- Sources Sought for Sequencing Platform

Notice Date
6/4/2014
 
Notice Type
Sources Sought
 
NAICS
334516 — Analytical Laboratory Instrument Manufacturing
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB, 10401 Fernwood Drive, Suite 2NE70, MSC 4811, Bethesda, Maryland, 20817
 
ZIP Code
20817
 
Solicitation Number
NIAIDSS14T1676396
 
Archive Date
6/24/2014
 
Point of Contact
Jessica Portillo, Phone: 3014025760
 
E-Mail Address
jessica.portillo@nih.gov
(jessica.portillo@nih.gov)
 
Small Business Set-Aside
N/A
 
Description
National Institutes of Health is seeking to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are small businesses; HUBZone small businesses; service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification System (NAICS) code of 334516 with a size standard of 500 employees for the proposed acquisition of a Zephyr NGS Workstation plus 1 year warranty, a Sciclone NGSx Workstation plus 1 year warranty, an Air Compressor, an iBLOX Universal Table, Unit A; Pipet Tip-15, Art, box 10-96 Sterile, Zephyr NGS consumables Kit A, and Assy-kit of Sciclone NGS Consumables to perform next-generation sequencing sample preparation protocols on large numbers of nucleic acid samples from human subjects and animals. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. Background: The Vaccine Research Center at the National Institutes of Health conducts research that facilitates the development of effective AIDS vaccines. Activities in the Center include basic research to establish mechanisms of inducing long-lasting protective immunity against HIV and other pathogens that present special challenges to vaccine development, the conception, design, and preparation of vaccine candidates for HIV and related viruses, and laboratory analysis, animal testing, and clinical trials of such candidates. The VRC conducts a comprehensive program of research on the NIH intramural campus and work with scientists in academic, clinical, and industrial laboratories through a program of national and international collaborations. The VRC will actively seek industrial partners for the development, efficacy testing, and marketing of vaccines and focus the development of new methodologies and training opportunities that will benefit all HIV vaccine researchers. The potential scientific advances, methodologies, and resources will also provide the basis for research on vaccines for other diseases. Laboratory based projects/clinical support: The VRC lab's work in HIV infection in part involves analysis of the clonal composition of CD8 T cells that respond to HIV and the interaction with HIV quasispecies. Escape from adaptive T cell immunity through viral epitope mutation is considered to be a major obstacle to the development of vaccines that aim to elicit cellular immunity. The VRC investigates the molecular determinants of this phenomenon at the level of the T cell receptor-epitope contact interface, and defines structural motifs that govern the pace and pattern of epitope escape. The practical consequences of the findings suggest that vaccine strategies should elicit responding T cells that are qualitatively superior, in terms of clonotypic composition, to those elicited in natural infection. Contractor Requirements •Segregation of pre-PCR and post-PCR library preparation steps. I.e., two different robots physically separated to prevent cross-contamination. •96-well pipetting heads for processing of up to 96 samples, completely in parallel/simultaneously. (Essential feature needed) •For the pre-PCR robot, large (>20-plate) deck space with extra reserve plates to provide enough clean pipet tips so that multiple different steps requiring different reagents may all be performed with walk-away automation. I.e., a person is not required to stand by the robot as it works and replenish clean tip boxes. •Availability from the company of pre-written and validated protocols for "mRNA seq" library construction and other key protocols performed by our research group. Any potential offers should respond with their capability statement by June 9, 2014. Capability statements must reference similar work that has been performed by the offeror and the dollar value of that work. Potential offers must indicate business size in their capability statement. This is a market survey, not a request for proposals. All submissions and questions must be directed in writing, to Jessica Portillo at jessica.portillo@nih.gov.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/AMOB/NIAIDSS14T1676396/listing.html)
 
Place of Performance
Address: Bethesda, Maryland, 20892, United States
Zip Code: 20892
 
Record
SN03385083-W 20140606/140604234833-9f5e04add58df0c7f9218d2c57f798eb (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.